Pharmabiz21m
Lexicon completes patient enrollment in phase 2B PROGRESS study of LX9211 in diabetic peripheral neuropathic pain
Lexicon completes patient enrollment in phase 2B PROGRESS study of LX9211 in diabetic peripheral neuropathic pain: The Woodlands, Texas Thursday, November 28, 2024, 12:00 Hrs [IST ...
Pharmabiz42m
Biocon Biologics supports Diabetes Africa to drive progress in embedding specialist nurses in Ethiopia
Biocon Biologics supports Diabetes Africa to drive progress in embedding specialist nurses in Ethiopia: Our Bureau, Bengaluru Thursday, November 28, 2024, 11:40 Hrs [IST] Biocon B ...
Pharmabiz2h
Kelun-Biotech’s TROP2 ADC sacituzumab tirumotecan receives China NMPA marketing approval for 2L+ advanced or metastatic TNBC
Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd., a holding subsidiary of Kelun Pharmaceutical, which focuses on the R&D, manufacturing, commercialization and global collaboration of innovative ...
Pharmabiz1h
VectorBuilde & Sartorius ink strategic cooperation agreement to advance biopharmaceutical innovation
VectorBuilde & Sartorius ink strategic cooperation agreement to advance biopharmaceutical innovation: Chicago, Illinois Thursday, November 28, 2024, 11:00 Hrs [IST] VectorBuilder, ...
Pharmabiz22h
Bry-Air conducts 14th Biannual Eye Camp at Moga, Punjab, to celebrate 60 years of the company
Bry-Air conducts 14th Biannual Eye Camp at Moga, Punjab, to celebrate 60 years of the company: Our Bureau, Mumbai Wednesday, ...
Pharmabiz4h
PCI asks all pharmacy institutions to appoint nodal officers related to award of scholarship
PCI asks all pharmacy institutions to appoint nodal officers related to award of scholarship: Gireesh Babu, New Delhi ...
Pharmabiz3h
Novartis Kisqali receives European approval in a broad population of patients with HR+/HER2- early breast cancer at high risk of recurrence
Novartis Kisqali receives European approval in a broad population of patients with HR+/HER2- early breast cancer at high risk of recurrence: Basel Thursday, November 28, 2024, 09: ...
Pharmabiz4h
DGFT updates import policy for pharma in sync with Finance Act 2024
DGFT updates import policy for pharma in sync with Finance Act 2024: Shardul Nautiyal, Mumbai Thursday, November 28, 2024, 08:00 Hrs [IST] The Union ministry of commerce & industr ...
Pharmabiz4h
Indian healthcare industry turns to technology to address fragmented payment landscape
Indian healthcare industry turns to technology to address fragmented payment landscape: Nandita Vijayasimha, Bengaluru Thursday, November 28, 2024, 08:00 Hrs [IST] Indian healthca ...
Pharmabiz4h
BIS prioritises standard development for 214 critical medical devices by December 2025
BIS prioritises standard development for 214 critical medical devices by December 2025: Our Bureau, New Delhi Thursday, November 28, 2024, 08:00 Hrs [IST] The Bureau of Indian Sta ...
Pharmabiz12h
Cassava Sciences’ ReThink-ALZ phase 3 study of simufilam in mild-to-moderate AD fails to meet co-primary endpoints
Cassava Sciences, Inc., a clinical-stage biotechnology company focused on developing a novel, investigational treatment for Alzheimer’s disease (AD) dementia, announced that the topline results from ...
Pharmabiz19h
BioNxt reports expansion of its next-generation product pipeline with innovative solutions for autoimmune diseases and longevity
BioNxt reports expansion of its next-generation product pipeline with innovative solutions for autoimmune diseases and longevity: Vancouver, BC Wednesday, November 27, 2024, 17:00 ...